• Afya posted 1Q26 revenue of R$ 1.01 billion, up 8.2% year over year.
• Net income rose 1.8% to R$ 261.76 million, while adjusted EBITDA climbed 4% to R$ 511.42 million as margin narrowed 2 percentage points to 50.5%.
• Free cash flow totaled R$ 376 million, with cash and cash equivalents at R$ 1.33 billion and operating cash conversion at 92.5%.
• Ecosystem outreach fell 4.3% to 303,553 users, while total approved medical seats increased to 3,768 following authorization of 63 additional seats at Afya Abaetetuba.
• Afya reaffirmed 2026 guidance for revenue of R$ 3.95 billion to R$ 4.1 billion and adjusted EBITDA of R$ 1.7 billion to R$ 1.8 billion, citing 100% occupancy and a 4.6% year-over-year rise in medical school net average ticket excluding acquisitions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Afya Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001292814-26-002873), on May 07, 2026, and is solely responsible for the information contained therein.